US House Energy and Commerce Committee Moves QALY Ban to Full House Vote
March 27, 2023
The US House Energy and Commerce Committee voted on Friday, March 24th, to advance a bill to a full House vote that would ban the use of quality adjusted life years (QALY) in therapeutic value-assessments. Some representatives argue that the bill is necessary, alleging the metric discriminates against people with disabilities. Other representatives argue the bill overreaches and would complicate upcoming drug price negotiations.
According to Politico, “The Campaign for Sustainable Rx Pricing, whose members include AARP, insurer trade group AHIP, the American Hospital Association and the Pharmaceutical Care Management Association, which represents pharmacy benefit managers, wrote to Rodgers opposing the legislation. The coalition argued it would restrict the information that patients and providers would have about treatment values and effectiveness. They also said it would put unnecessary restrictions on drug pricing negotiations.”
To read more, click here.
(Source: Politico, March 27th, 2023)